Free Trial

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Lowers Stock Holdings in Mettler-Toledo International Inc. (NYSE:MTD)

Mettler-Toledo International logo with Computer and Technology background

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC cut its position in shares of Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 2.3% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 191,332 shares of the medical instruments supplier's stock after selling 4,446 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.91% of Mettler-Toledo International worth $286,941,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. EverSource Wealth Advisors LLC raised its position in Mettler-Toledo International by 8.0% during the 1st quarter. EverSource Wealth Advisors LLC now owns 95 shares of the medical instruments supplier's stock valued at $117,000 after purchasing an additional 7 shares in the last quarter. UMB Bank n.a. raised its position in Mettler-Toledo International by 6.6% during the 2nd quarter. UMB Bank n.a. now owns 113 shares of the medical instruments supplier's stock valued at $158,000 after purchasing an additional 7 shares in the last quarter. Massmutual Trust Co. FSB ADV raised its position in Mettler-Toledo International by 7.2% during the 2nd quarter. Massmutual Trust Co. FSB ADV now owns 119 shares of the medical instruments supplier's stock valued at $166,000 after purchasing an additional 8 shares in the last quarter. DT Investment Partners LLC raised its position in Mettler-Toledo International by 13.3% during the 3rd quarter. DT Investment Partners LLC now owns 68 shares of the medical instruments supplier's stock valued at $102,000 after purchasing an additional 8 shares in the last quarter. Finally, Suncoast Equity Management raised its position in Mettler-Toledo International by 2.0% during the 3rd quarter. Suncoast Equity Management now owns 460 shares of the medical instruments supplier's stock valued at $690,000 after purchasing an additional 9 shares in the last quarter. 95.07% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on MTD. Wells Fargo & Company cut their price target on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an "equal weight" rating on the stock in a report on Monday, November 11th. Evercore ISI lifted their price target on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an "in-line" rating in a report on Tuesday, October 1st. Robert W. Baird cut their price target on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a "neutral" rating on the stock in a report on Monday, November 11th. Stifel Nicolaus cut their price target on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a "buy" rating on the stock in a report on Monday, November 11th. Finally, JPMorgan Chase & Co. lifted their price target on Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the company a "neutral" rating in a report on Monday, August 5th. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and two have assigned a buy rating to the company. According to MarketBeat, Mettler-Toledo International has a consensus rating of "Hold" and an average price target of $1,338.75.

Get Our Latest Report on Mettler-Toledo International

Mettler-Toledo International Stock Performance

MTD stock traded up $7.80 on Friday, hitting $1,251.20. 74,430 shares of the company's stock were exchanged, compared to its average volume of 136,894. Mettler-Toledo International Inc. has a 12-month low of $1,068.33 and a 12-month high of $1,546.93. The firm has a 50 day moving average price of $1,345.17 and a two-hundred day moving average price of $1,393.97. The stock has a market cap of $26.40 billion, a P/E ratio of 33.72, a price-to-earnings-growth ratio of 4.10 and a beta of 1.16.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, topping the consensus estimate of $10.00 by $0.21. The firm had revenue of $954.54 million for the quarter, compared to the consensus estimate of $941.93 million. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. Sell-side analysts expect that Mettler-Toledo International Inc. will post 40.39 earnings per share for the current fiscal year.

Insider Buying and Selling at Mettler-Toledo International

In other Mettler-Toledo International news, Director Elisha W. Finney sold 76 shares of the business's stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the sale, the director now owns 240 shares in the company, valued at approximately $314,820. The trade was a 24.05 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 1.94% of the company's stock.

About Mettler-Toledo International

(Free Report)

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

Featured Articles

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

Should you invest $1,000 in Mettler-Toledo International right now?

Before you consider Mettler-Toledo International, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mettler-Toledo International wasn't on the list.

While Mettler-Toledo International currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Like this article? Share it with a colleague.

Featured Articles and Offers

UnitedHealth Group: A Healthcare Giant with Strong Dividends

UnitedHealth Group: A Healthcare Giant with Strong Dividends

UnitedHealth Group (UNH) is a powerhouse in healthcare, offering an impressive 14.7% average annual dividend increase over the last three years.

Related Videos

Inflation-Busting Dividends: 3 Stocks Raising Payouts 4X Faster

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines